The Centers for Disease Control and Prevention announced on May 18, 2026 that, for the next 30 days, anyone who does not hold a U.S. passport and has traveled to the Democratic Republic of the Congo, South Sudan or Uganda will be denied entry to the United States. The measure, described by CDC officials as a precautionary step, is intended to give the agency additional time to evaluate the risk of Ebola transmission from the ongoing outbreaks in those three countries.
CDC staff have been monitoring the Ebola situation in Central and East Africa for weeks, tracking new cases as they appear. The agency’s director, Dr. Rochelle Walensky, said the suspension reflects the CDC’s core mission to protect the health and safety of Americans.
The U.S. administration echoed that sentiment, emphasizing that safeguarding American citizens remains a top priority. Travel bans are not new tools in the U.S. public‑health arsenal. Similar restrictions were employed during the early stages of the COVID‑19 pandemic and were heavily debated during the 2014 West African Ebola crisis.
The underlying rationale is straightforward: limit the entry of a pathogen that spreads through direct contact with infected bodily fluids and can quickly overwhelm medical facilities. However, officials acknowledge that such bans can disrupt families, impede trade and strain diplomatic relations.
While the restriction applies to non‑U.S. passport holders, Americans returning from the three affected nations will still be permitted entry, though they will undergo screening and monitoring upon arrival. This distinction makes the order a targeted measure rather than a blanket prohibition. The World Health Organization, working alongside the CDC and other international partners, continues efforts to contain the Ebola outbreaks.
Challenges cited include fragile health systems, cross‑border movement of people and the high case‑fatality rate of the virus. No widely licensed vaccine is currently available in the affected regions, although experimental treatments exist.
The 30‑day period is intended as a window for the CDC to gather additional data, consult with global health agencies and decide whether to extend the ban or allow it to lapse. Decisions will be made at the CDC headquarters in Atlanta, based on field reports from Central and East Africa. If the outbreaks are brought under control within the month, the travel restriction could end as scheduled; a surge in cases could prompt a renewal.
By limiting entry to travelers without U.S. passports, the United States is exercising its sovereign authority to close its borders when it judges the risk to be real. The virus has not yet entered U.S. territory, and CDC officials say the agency aims to keep it that way.
Whether the ban proves effective or largely symbolic will depend on factors beyond CDC control, including the virus’s behavior, the response of local governments and the cooperation of travelers. For now, the order remains in force, and the countdown has begun.
